BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16762011)

  • 1. Risk factors for oral hairy leukoplakia in HIV-infected adults of Brazil.
    Moura MD; Grossmann Sde M; Fonseca LM; Senna MI; Mesquita RA
    J Oral Pathol Med; 2006 Jul; 35(6):321-6. PubMed ID: 16762011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral candidosis and oral hairy leukoplakia as predictors of HAART failure in Brazilian HIV-infected patients.
    Miziara ID; Weber R
    Oral Dis; 2006 Jul; 12(4):402-7. PubMed ID: 16792726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults.
    Chattopadhyay A; Caplan DJ; Slade GD; Shugars DC; Tien HC; Patton LL
    Community Dent Oral Epidemiol; 2005 Feb; 33(1):35-44. PubMed ID: 15642045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of oral candidiasis and oral hairy leukoplakia in HIV-infected adults in North Carolina.
    Chattopadhyay A; Caplan DJ; Slade GD; Shugars DC; Tien HC; Patton LL
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jan; 99(1):39-47. PubMed ID: 15599347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study.
    Tappuni AR; Fleming GJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Dec; 92(6):623-8. PubMed ID: 11740479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of Epstein-Barr virus, cytomegalovirus and human papillomavirus in normal oral mucosa of HIV-infected and renal transplant patients.
    Ammatuna P; Campisi G; Giovannelli L; Giambelluca D; Alaimo C; Mancuso S; Margiotta V
    Oral Dis; 2001 Jan; 7(1):34-40. PubMed ID: 11354920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL; Vale DA; Magalhães MH
    J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral manifestations of HIV infection in relation to clinical and CD4 immunological status in northern and southern Thai patients.
    Kerdpon D; Pongsiriwet S; Pangsomboon K; Iamaroon A; Kampoo K; Sretrirutchai S; Geater A; Robison V
    Oral Dis; 2004 May; 10(3):138-44. PubMed ID: 15089922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
    Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
    Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral and constitutional manifestations of HIV-infected hospital patients in Northern Vietnam.
    Jensen TO; Tam VV; Mai NT; Ut do Q; Dat DD; Lien NT; Nga NT; Bygbjerg IC
    Southeast Asian J Trop Med Public Health; 2005 Nov; 36(6):1459-68. PubMed ID: 16610648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of oral lesions and periodontal diseases in HIV-infected patients on antiretroviral therapy.
    Kroidl A; Schaeben A; Oette M; Wettstein M; Herfordt A; Häussinger D
    Eur J Med Res; 2005 Oct; 10(10):448-53. PubMed ID: 16287607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral manifestations of HIV infection in adult patients from the province of Sancti Spiritus, Cuba.
    Carpio E; López V; Fardales V; Benítez I
    J Oral Pathol Med; 2009 Jan; 38(1):126-31. PubMed ID: 19192058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral manifestations of HIV infection in patients receiving highly active antiretroviral therapy (HAART) in Bahia, Brazil.
    da Silva CA; Dourado I; Dahia SR; Harzheim E; Rutherford GW
    J Public Health Dent; 2008; 68(3):178-81. PubMed ID: 18248345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity, specificity, and positive predictive value of oral opportunistic infections in adults with HIV/AIDS as markers of immune suppression and viral burden.
    Patton LL
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Aug; 90(2):182-8. PubMed ID: 10936837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk indicators for HIV-associated jointly occurring oral candidiasis and oral hairy leukoplakia.
    Chattopadhyay A; Patton LL
    AIDS Patient Care STDS; 2007 Nov; 21(11):825-32. PubMed ID: 18240892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brazilian HIV-infected population: assessment of the needs of endodontic treatment in the post-highly active antiretroviral therapy era.
    de Brito LC; da Rosa MA; Lopes VS; e Ferreira EF; Vieira LQ; Sobrinho AP
    J Endod; 2009 Sep; 35(9):1178-81. PubMed ID: 19720212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus and Epstein Barr virus in oral hairy leukoplakia among HIV positive Venezuelan patients.
    Correnti M; González X; Avila M; Perrone M; Rivera H
    Acta Odontol Latinoam; 2010; 23(2):117-23. PubMed ID: 21053684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral manifestations in HIV/AIDS infected patients from India.
    Sharma G; Pai KM; Suhas S; Ramapuram JT; Doshi D; Anup N
    Oral Dis; 2006 Nov; 12(6):537-42. PubMed ID: 17054765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral complication risks after invasive and non-invasive dental procedures in HIV-positive patients.
    Campo J; Cano J; del Romero J; Hernando V; Rodríguez C; Bascones A
    Oral Dis; 2007 Jan; 13(1):110-6. PubMed ID: 17241440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective analysis of oral hairy leukoplakia in South Australia.
    Logan RM; Coates EA; Pierce AM; Wilson DF
    Aust Dent J; 2001 Jun; 46(2):108-13. PubMed ID: 11491226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.